Literature DB >> 1839079

Components of the plasminogen-plasmin system in human tumor cell lines.

H C Kwaan1, H N Keer, J A Radosevich, J F Cajot, R Ernst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1839079     DOI： 10.1055/s-2007-1002607

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN： 0094-6176            Impact factor:   4.180


× No keyword cloud information.
  5 in total

1.  Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.

Authors:  G A Soff; J Sanderowitz; S Gately; E Verrusio; I Weiss; S Brem; H C Kwaan
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 2.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

3.  Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.

Authors:  M H Zheng; Y Fan; A Panicker; A Smith; T Robertson; S Wysocki; P Robbins; J M Papadimitriou; D J Wood
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

Review 4.  Hemostatic changes in patients with brain tumors.

Authors:  L Thoron; E Arbit
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 5.  The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets.

Authors:  Ashna A Kumar; Benjamin J Buckley; Marie Ranson
Journal:  Biomolecules       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.